Population pharmacogenetic pharmacokinetic modeling for flip-flop phenomenon of enteric-coated mycophenolate sodium in kidney transplant recipients

A mechanism-Based Approach for Absorption Modeling: The Gastro-Intestinal Transit Time (GITT) Model

(2012) Emilie Hénin et al.   AAPS Journal

Polymorphisms of UGT1A9 and UGT2B7 influence the pharmacokinetics of mycophenolic acid after a single oral dose in healthy Chinese volunteers

(2012) Dong Guo et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

A pilot study on area under curve of mycophenolic acid as a guide for its optimal use in renal transplant recipients

(2012) YK Gupta et al.   INDIAN JOURNAL OF MEDICAL RESEARCH

Limited-Sampling Strategy for Mycophenolic Acid in Renal Transplant Recipients Reciving Enteric-Coated Mycophenolate Sodium and Tacrolimus

(2012) Ana I. Sánchez Fructuoso et al.   THERAPEUTIC DRUG MONITORING

SLCO1B1genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients

(2010) Hugues Michelon et al.   PHARMACOGENOMICS

Pharmacogenetic Impact of UDP-Glucuronosyltransferase Metabolic Pathway and Multidrug Resistance–Associated Protein 2 Transport Pathway on Mycophenolic Acid in Thoracic Transplant Recipients: An Exploratory Study

(2010) Lillian S. L Ting et al.   PHARMACOTHERAPY

The Role of Organic Anion–Transporting Polypeptides and Their Common Genetic Variants in Mycophenolic Acid Pharmacokinetics

(2009) N Picard et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

UGT1A9 -275T>A/-2152C>T Polymorphisms Correlate With Low MPA Exposure and Acute Rejection in MMF/Tacrolimus-Treated Kidney Transplant Patients

(2009) R H N van Schaik et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Limited sampling strategies for mycophenolic acid in solid organ transplantation: a systematic review

(2009) Nicole K Bruchet et al.   Expert Opinion on Drug Metabolism & Toxicology

Does the Evidence Support the Use of Mycophenolate Mofetil Therapeutic Drug Monitoring in Clinical Practice? A Systematic Review

(2009) Simon R. Knight et al.   TRANSPLANTATION

Current target ranges of mycophenolic acid exposure and drug-related adverse events: A 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients

(2008) Dirk R.J. Kuypers et al.   CLINICAL THERAPEUTICS

Influence of Drug Transporters and UGT Polymorphisms on Pharmacokinetics of Phenolic glucuronide Metabolite of Mycophenolic Acid in Japanese Renal Transplant Recipients

(2008) Masatomo Miura et al.   THERAPEUTIC DRUG MONITORING

Influence of uridine diphosphate (UDP)-glucuronosyltransferases and ABCC2 genetic polymorphisms on the pharmacokinetics of mycophenolic acid and its metabolites in Chinese renal transplant recipients

(2008) W.-X. Zhang et al.   XENOBIOTICA